These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34017101)

  • 21. Accuracy of a portable international normalized ratio monitor for patients receiving a low molecular weight heparin as a bridge pending full oral anticoagulant efficacy.
    Meurin P; Tabet JY; Monchi M; Weber H; Fabre C; Gibier B; Renaud N; Driss AB
    Thromb Res; 2010 Feb; 125(2):192-5. PubMed ID: 19942256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A group sequential approach to evaluation of bridging studies.
    Hsiao CF; Xu JZ; Liu JP
    J Biopharm Stat; 2003 Nov; 13(4):793-801. PubMed ID: 14584723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weighted evidence approach of bridging study.
    Tsou HH; Tsong Y; Liu JT; Dong X; Wu Y
    J Biopharm Stat; 2012 Sep; 22(5):952-65. PubMed ID: 22946942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].
    Schellong SM; Riess H; Spannagl M; Omran H; Schwarzbach M; Langer F; Gogarten W; Bramlage P; Bauersachs RM
    Anaesthesist; 2018 Aug; 67(8):599-606. PubMed ID: 29926118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intracranial pressure on bridging veins in rats.
    Auer LM; Ishiyama N; Hodde KC; Kleinert R; Pucher R
    J Neurosurg; 1987 Aug; 67(2):263-8. PubMed ID: 3598685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimally Interrupted Non-Vitamin K Antagonist Oral Anticoagulants vs. Bridging Therapy and Uninterrupted Vitamin K Antagonists During Atrial Fibrillation Ablation: A Retrospective Single-Center Study.
    Tang L; Liu H; Deng H; Zhan X; Fang X; Liao H; Liu Y; Fu L; Fu Z; Liu H; Wu S; Xue Y
    Front Med (Lausanne); 2020; 7():197. PubMed ID: 32582721
    [No Abstract]   [Full Text] [Related]  

  • 27. Bridging studies in clinical development.
    Liu JP; Chow SC
    J Biopharm Stat; 2002 Aug; 12(3):359-67. PubMed ID: 12448577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survey of pharmacists' subtherapeutic INR management and anticoagulation bridging practices.
    Maxwell WD; Shrader SP; Moore KG; Lu ZK; White SF
    J Clin Pharm Ther; 2015 Oct; 40(5):531-538. PubMed ID: 26086075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The capability approach as a bridging framework across health promotion settings: theoretical and empirical considerations.
    Frahsa A; Abel T; Gelius P; Rütten A;
    Health Promot Int; 2021 Apr; 36(2):493-504. PubMed ID: 32989442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal designs for regional bridging studies using the Bayesian power prior method.
    Nagase M; Ueda S; Higashimori M; Ichikawa K; Dunyak J; Al-Huniti N
    Pharm Stat; 2020 Jan; 19(1):22-30. PubMed ID: 31448511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bridging the gap in mental health approaches between east and west: the psychosocial consequences of radiation exposure.
    Yevelson II; Abdelgani A; Cwikel J; Yevelson IS
    Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1551-6. PubMed ID: 9467081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical evaluation of drug efficacy for bridging study in companion diagnostic test trials.
    Bu Y; Zhou XH
    J Biopharm Stat; 2016; 26(6):1118-1124. PubMed ID: 27649095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Documentation of various approaches and outcomes in patients on warfarin undergoing dental procedures: a review article.
    Shaer FE; Raslan I; Osaimi NA; Bawazeer G; Alayobi F; Alhogbani T; Kharabsheh S; Habeeb WA
    Am J Cardiovasc Dis; 2016; 6(3):109-17. PubMed ID: 27679745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diversifying the Midwifery Workforce: Inclusivity, Culturally Sensitive Bridging, and Innovation.
    Tyson H; Wilson-Mitchell K
    J Midwifery Womens Health; 2016 Nov; 61(6):752-758. PubMed ID: 27860141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial bridging.
    Alegria JR; Herrmann J; Holmes DR; Lerman A; Rihal CS
    Eur Heart J; 2005 Jun; 26(12):1159-68. PubMed ID: 15764618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of different bridging anticoagulation therapies used after mechanical heart valve replacement in Chinese patients - a prospective cohort study.
    Li BX; Liu SD; Qi L; Sun S; Sun W; Li YM; Song B; Wu XA
    J Cardiothorac Surg; 2020 Feb; 15(1):40. PubMed ID: 32093747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative bridging of anticoagulation: towards a more reserved approach.
    Mol GCM; Büller HR; Sinnige HAM; Péquériaux NCV; Coppens M
    Neth J Med; 2019 Oct; 77(8):280-286. PubMed ID: 31814575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of heparin infusion intensity on outcomes for bridging hospitalized patients with atrial fibrillation.
    Warden BA; Diep C; Ran R; Thomas M; Cigarroa JE
    Clin Cardiol; 2019 Oct; 42(10):995-1002. PubMed ID: 31483512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin-bridging therapy is associated with a high risk of post-polypectomy bleeding regardless of polyp size.
    Ishigami H; Arai M; Matsumura T; Maruoka D; Minemura S; Okimoto K; Kasamatsu S; Saito K; Nakagawa T; Katsuno T; Yokosuka O
    Dig Endosc; 2017 Jan; 29(1):65-72. PubMed ID: 27368065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bridging of oral anticoagulation with low-molecular-weight heparin: experience in 373 patients with renal insufficiency undergoing invasive procedures.
    Hammerstingl C; Omran H;
    Thromb Haemost; 2009 Jun; 101(6):1085-90. PubMed ID: 19492151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.